Association of TUSC1 and DPF3 gene polymorphisms with male infertility by Sato, Youichi et al.
Association of TUSC1 and DPF3 gene polymorphisms with male infertility 
Youichi Sato1,*, Chise Hasegawa1, Atsushi Tajima2, Shiari Nozawa3, Miki Yoshiike3, 
Eitetsue Koh4, Jiro Kanaya4, Mikio Namiki4,5, Kiyomi Matsumiya6, Akira Tsujimura7, 
Kiyoshi Komatsu8, Naoki Itoh9, Jiro Eguchi10, Aiko Yamauchi1, Teruaki Iwamoto3,11 
1Department of Pharmaceutical Information Science, Graduate School of Biomedical 
Sciences, Tokushima University, Tokushima, 770-8505, Japan 
2Department of Bioinformatics and Genomics, Graduate School of Advanced Preventive 
Medical Sciences, Kanazawa University, Kanazawa, 920-8640, Japan 
3Department of Urology, St. Marianna University School of Medicine, Kawasaki, 216-
8511, Japan 
4Department of Urology, Kanazawa University Graduate School of Medical Sciences, 
Kanazawa, 920-8641, Japan 
5Department of Urology, Hasegawa Hospital, Toyama 930-0065, Japan 
6Department of Urology, Suita Tokushukai Hospital, Osaka, 565-0814, Japan 
7Department of Urology, Juntendo University Urayasu Hospital, Urayasu, 279-0021, 
Japan 
8Department of Urology, Harasanshinkai Hospital, Fukuoka, 812-0033, Japan 
9Department of Urology, NTT East Sapporo Hospital, Sapporo, 060-0061, Japan 
10Department of Urology, Sasebo Kyosai Hospital, Sasebo, 857-8575, Japan 
11Center for Infertility and IVF, International University of Health and Welfare Hospital, 
Nasushiobara, 329-2763, Japan 
This is a post-peer-review, pre-copyedit version of an article published in Journal of Assisted Reproduction and Genetics. 
The final authenticated version is available online at: https://doi.org/10.1007/s10815-017-1052-x.
*Correspondence to: Youichi Sato, Ph.D. 
Department of Pharmaceutical Information Science, Institute of Biomedical Sciences, 
Tokushima University Graduate School  
1-78-1 Sho-machi, Tokushima, 770-8505, Japan 
Phone: +81-88-633-7253; FAX: +81-88-633-7253 
E-mail: youichi.sato@tokushima-u.ac.jp 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Abstract 
Purpose Recently, a genome-wide association studies of a Hutterite population in the 
USA revealed that five single nucleotide polymorphisms (SNPs) with a significant 
association with sperm quality and/or function in ethnically diverse men from Chicago 
were significantly correlated with family size. Of these, three SNPs (rs7867029, 
rs7174015, and rs12870438) were found to be significantly associated with the risk of 
azoospermia and/or oligozoospermia in a Japanese population. In this study, we 
investigated whether the rs10966811 (located in an intergenic region between the TUSC1 
and IZUMO3 genes) and rs10129954 (located in the DPF3 gene) SNPs, previously 
related to family size, are associated with male infertility. In addition, we performed 
association analysis between rs12348 in TUSC1 and rs2772579 in IZUMO3 and male 
infertility. 
Methods We genotyped 145 patients with infertility (including 83 patients with 
azoospermia, and 62 with oligozoospermia) and 713 fertile controls by PCR-RFLP 
technique for polymorphism. Because rs10966811 has no restriction sites, the SNP 
rs12376894 with strong linkage disequilibrium was selected as an alternative to 
rs10966811. 
Results There was a statistically significant association between rs12376894 proxy SNP 
of rs10966811, and oligozoospermia. A statistically significant association between 
rs10129954 and azoospermia, and oligozoospermia were observed. When we assessed 
the relationship between rs12348 in TUSC1 and rs2772579 in IZUMO3 and male 
infertility traits, we found that rs12348 in TUSC1 was significantly associated with 
azoospermia and oligozoospermia, but rs2772579 in IZUMO3 was not associated with 
male infertility. 
Conclusion We found that the polymorphisms in TUSC1 and DPF3 displayed strong 
associations with male infertility. 
 
Keywords: single nucleotide polymorphism · male infertility · azoospermia · 
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Introduction 
 The main cause of male infertility is spermatogenic failure, of which there are 
three general classifications: azoospermia, oligozoospermia, and asthenozoospermia. It is 
thought that lifestyle factors such as cigarette smoking and alcohol abuse, as well as 
environmental factors such as exposure to certain chemicals are potential causes of 
spermatogenic failure [1]. In addition, genetic factors such as gene mutations and 
chromosomal aberrations can also be related to male infertility. Previously, three genome-
wide association studies (GWASs) revealed that several single nucleotide polymorphisms 
(SNPs) were associated with male infertility including azoospermia and/or 
oligozoospermia [2–4]. Another GWAS, including 269 members of a Hutterite population 
in the USA, showed that of 41 SNPs associated with family size or birth rate, nine were 
also associated with reduced sperm quality and/or function in ethnically diverse men from 
Chicago [5]. Recently, we conducted a case-control association study to assess whether 
four SNPs, associated with semen parameters in men from Chicago with minor allele 
frequencies > 0.05 in the HapMap-JPT population, are associated with infertility 
(including azoospermia and oligozoospermia) in Japanese males. The SNPs assessed and 
their locations were as follows: rs7867029 (downstream of phosphoserine 
aminotransferase 1 [PSAT1], rs7174015 (in the ubiquitin specific peptidase 8 [USP8] 
gene, rs12870438 (in the epithelial stromal interaction protein 1 [EPSTI1] gene, and 
rs724078 (upstream of MAS1 oncogene-like protein [MAS1L] and downstream of 
ubiquitin D [UBD]). We found that rs7867029, rs7174015, and rs12870438 were 
significantly associated with the risk of azoospermia and/or oligozoospermia [6]. These 
SNPs were previously related to family size in the Hutterite GWAS. Conversely, rs724078, 
which was not associated with male infertility, was associated with birth rate in the 
previous GWAS. From this data, we predicted that other SNPs, in which significant 
association with family size was indicated in the previous Hutterite GWAS, may also be 
related to male infertility in the Japanese population. Of nine SNPs associated with 
reduced sperm quality and/or function in the men from Chicago, five SNPs were 
associated with family size in the previous GWAS [5]. These included rs10966811 
(downstream of the tumor suppressor candidate 1 [TUSC1] gene) and rs10129954 
(located in the D4, zinc and double plant homeodomain fingers, family 3 [DPF3] gene), 
as well as three SNPs (rs7867029, rs7174015 and rs12870438), which were analyzed 
previously [6]. In this study, we assessed whether rs10966811 and rs10129954 are 
associated with male infertility including azoospermia, and oligozoospermia. 
Materials and Methods 
Subjects and clinical trait measurements 
In total, 145 consecutive patients who presented with infertility at the 
Department of Urology, St. Mariana University Hospital, Kanagawa Prefecture, Japan, 
were recruited from 2000 to 2011. Of these patients, 83 (aged 33.0 ± 5.6 years; mean ± 
SD) were diagnosed as having azoospermia, and 62 (aged 34.8 ± 6.2 years; mean ± SD) 
were diagnosed as having oligozoospermia. Some of the individuals in this study and 
diagnostic criteria have been described in previous reports [6–8]. Briefly, semen analysis 
was performed in accordance with the fourth edition of World Health Organization 
(WHO) Laboratory Manual for the Examination of Human Semen [9]. According to the 
criteria described in the fourth edition WHO guidelines (1999), patients with azoospermia 
were diagnosed on the basis of semen analysis (absence of sperm in ejaculate), serum 
hormone levels, and the results of physical examinations. Oligozoospermia was defined 
as a sperm concentration of less than 20 × 106/mL. We excluded patients with any other 
known cause of infertility (i.e., obstructive azoospermia, varicocele, cryptorchidism, 
hypogonadotropic hypogonadism, karyotype abnormalities, or complete deletion of AZF 
a, b, or c). Deletions in AZF a, b, and c were analyzed according to European Academy 
of Andrology and the European Molecular Genetics Quality Network best practice 
guidelines [10]. 
The 713 fertile Japanese men (aged 31.1 ± 4.8 years; mean ± SD) used as the 
control group were the partners of pregnant women who attended obstetric clinics in four 
cities in Japan (Sapporo, Kanazawa, Osaka, and Fukuoka). Some of the fertile individuals 
in this study and the eligibility criteria for participants have been described in previous 
reports [11–15]. Briefly, the eligibility criteria for the male participants were as follows: 
age 20–45 years at the time of invitation by the hospital, and that both the participant and 
his mother were born in Japan and currently living there as well. In addition, the 
pregnancy of their partner had to have been the result of conception by sexual intercourse 
and not through fertility treatment. 
 
SNP selection and genotyping  
 For the association analysis, the SNP rs12376894 was selected as an alternative 
to rs10966811, because rs10966811 has no restriction sites, and rs10966811 and 
rs12376894 are in strong linkage disequilibrium (LD) (r2=0.91, |D′|=1), according to data 
from JPT in 1000 genomes phase 1 release version 3 dataset [16]. rs12348 and rs2772579, 
located in TUSC1 and IZUMO family member 3 (IZUMO3), respectively, were selected 
as tag SNPs using SNPinfo Web Server (http://snpinfo.niehs.nih.gov/) [17], owing to their 
strong LD (r2 > 0.8), minor allele frequency > 0.05, and a minimum of two SNPs tagged 
each. 
 Genomic DNA was extracted from the peripheral blood samples of subjects 
using a QIAamp DNA blood kit (Qiagen; Tokyo, Japan) as previously described [6–8, 
12–15]. The rs12376894, rs10129954, rs12348, and rs2772579 SNPs were detected by 
restriction fragment length polymorphism PCR using the following primer sets: 
rs12376894, 5'-CGGTGTAGAAAATGCGACCAA-3' (forward) and 5'-
ATCACCCCATCGTCAGTCAT-3' (reverse); rs10129954, 5'- 
TTGGCTCTGAACCCAAGCAA -3' (forward) and 5'-TGATTGGTCTCCCAGCCTCT-
3' (reverse); rs12348, 5'-TCGCCGCAACCTTTCAGATA-3' (forward) and 5'-
CCGCGGATACCTTGGACTAC-3' (reverse); and rs2772579, 5'-
GCGGGAAAAGTGGAGTCAGA-3' (forward) and 5'-
AGATTTCCCAGCAAGGAGCC-3' (reverse). DNA from each subject was amplified 
using EmeraldAmp MAX PCR Master Mix (TaKaRa Bio Inc., Otsu, Japan) under the 
following PCR cycling parameters: initial denaturation at 94°C for 3 min; 30 cycles of 
94°C for 30 s, 60°C for 30 s, and 72°C for 1 min; and final extension for 3 min at 72°C. 
The resulting PCR products were then digested at 37°C for 3 hours using the following 
restriction enzymes: EarI (rs12376894), HpyCH4IV (rs10129954), PvuII (rs12348), and 
Hpy166II (rs2772579); all of which were sourced from New England Biolabs Japan Inc., 
Tokyo, Japan. The digested products were separated by electrophoresis on 2.5% agarose 
gel. The following fragment sizes were used for allele identification on gels: for 
rs12376894, 594 bp (A-allele) and 287 + 307 bp (G-allele); for rs10129954, 738 bp (T-
allele) and 365 + 373 bp (C-allele); for rs12348, 633 bp (T-allele) and 269 + 364 bp (C-
allele); and for rs2772579, 250 bp (G-allele) and 74 + 176 bp (C-allele). 
 
Statistical analysis 
The fertile cohort was used as the control, and odds ratios (ORs) and their 95% 
confidence intervals (CIs) were calculated using logistic regression analysis. All 
statistical analyses were performed using R version 3.1.2 (The R Project for Statistical 
Computing [http://www.r-project.org]), and statistical significance was declared at P-
value < 0.05. HardyWeinberg equilibrium (HWE) was assessed in both patients with 
infertility and fertile control samples with a threshold of 0.05 by using Pearson chi-square 
test for genotypes. LD was calculated using PLINK version 1.07 [18] with JPT in 1000 
genomes phase 1 release version 3 dataset [16] or genotyped fertile control data in this 
study. 
Results 
The genotype and allele frequencies of rs12376894 and rs10129954 SNPs 
among 713 fertile controls and 83 patients with azoospermia, and 62 with 
oligozoospermia are summarized in Table 1. Two SNPs were in HWE in the both patients 
with infertility and fertile controls. 
To verify whether rs12376894 and rs10129954 SNPs are associated with male 
infertility traits, we carried out a case-control study using a logistic regression analysis 
under three comparative genetic models (additive, recessive, or dominant). The results of 
the logistic regression analysis are summarized in Table 2. There was a statistically 
significant association between rs12376894 and oligozoospermia in the recessive model 
(OR = 2.03, 95% CI = 1.17–3.52, P = 0.012). rs10129954 displayed significant 
association with azoospermia in all three models: log-additive (OR = 2.05, 95% CI = 
1.21–3.46, P = 7.4 × 10-3), recessive (OR = 17.60, 95% CI = 1.58–196.00, P = 0.020), 
and dominant (OR = 1.92, 95% CI = 1.09–3.38, P = 0.025); and with oligozoospermia in 
two models: log-additive (OR = 2.83, 95% CI = 1.61–4.97, P = 2.9 × 10-4), and dominant 
(OR = 2.83, 95% CI = 1.57–5.11, P = 5.6 × 10-4). 
rs10129954 is located in an intronic region of DPF3. Therefore, DPF3 protein 
may affect spermatogenesis, although there is no evidence. rs12376894 is located in an 
intergenic region between TUSC1 and IZUMO3. Then, we speculate that TUSC1 or 
IZUMO3 may be related to male infertility. We performed a further association analysis 
between TUSC1 and IZUMO3 polymorphisms and male infertility; rs12348 and 
rs2772579 were selected as tag SNPs respectively, according to the pairwise LD 
measurement. rs12348 is located in a 3' untranslated region (UTR) of TUSC1, and 
rs2772579 is located in a 5' UTR of IZUMO3. The genotype and allele frequencies of 
rs12348 and rs2772579 among 713 fertile controls, as well as 83 patients with 
azoospermia, and 62 with oligozoospermia are summarized in Table 3. These SNPs were 
in HWE in the both patients with infertility and fertile control group. Using a logistic 
regression analysis, a statistically significant association between rs12348 and 
azoospermia was observed in the recessive model (OR = 1.82, 95% CI = 1.07–3.10, P = 
0.028), and oligozoospermia in two models: log-additive (OR = 1.87, 95% CI = 1.29–
2.71, P = 8.8 × 10-4), and recessive (OR = 3.16, 95% CI = 1.82–5.50, P = 4.5 × 10-5) 
(Table 4). However, no association was found between rs2772579 and male infertility 
traits in three genetic models. 
To understand the relationship between rs12376894 and rs12348, we performed 
a conditional logistic regression analysis for azoospermia, and oligozoospermia adjusted 
for each SNP. The strength of association between two SNPs and azoospermia or 
oligozoospermia was not reduced (Table 5). Additionally, we calculated the pairwise LD 
between rs12376894 and rs12348 using genotyped fertile control data in this study 
Pairwise r2 values were low (r2 = 0.005). Therefore, it is suggested that rs12376894 and 
rs12348 are independently related to azoospermia and/or oligozoospermia. 
Discussion 
 In this study, we identified that the SNPs rs12376894 and rs10129954, which 
have been associated with family size in a genome-wide association study (GWAS) of a 
Hutterite population in the USA [5], were significantly correlated with azoospermia, 
and/or oligozoospermia in a Japanese population. rs12376894 is located 445.4 kb 
downstream of TUSC1 and 687.8 kb upstream of IZUMO3. Therefore, we speculate that 
TUSC1 or IZUMO3 may be contribute to spermatogenesis, and assessed whether TUSC1 
and IZUMO3 polymorphisms are related to male infertility. We found that rs12348 in 
TUSC1 was associated with azoospermia and oligozoospermia; an especially strong 
association was identified in the recessive model (TT versus TT+CC). However, 
rs2772579 in IZUMO3 was not associated with male infertility. TUSC1 has been 
suggested as a candidate tumor suppressor gene in several cancers [19–23], and it is 
reported that variation in TUSC1 and the surrounding region is associated with risk of 
cancers [24, 25]. It is also reported that TUSC1 variants are related to tanning ability [24], 
supernumerary teeth occurrence [26], amongst other traits. However, no evidence that 
TUSC1 contributes to spermatogenesis has yet been published. TUSC1 is an intronless 
gene, and major transcripts TUSC1-L (2.0-kb long) and TUSC1-S (1.5-kb long) have 
been detected in a wide range of human adult tissues [19]. Interestingly, two transcripts 
were most strongly expressed in human testes and another 1.1-kb transcript has been 
detected only in this organ [19]. Similarly, in mouse tissues, TUSC1-S was most strongly 
expressed in the testis [19]. Therefore, TUSC1 may have an important function in the 
testis. On the other hand, IZUMO3 was also strongly expressed in the testis. However, 
IZUMO3 is essential for the function of the gamete fusion rather than spermatogenesis 
[27]. 
 rs12376894, which displayed significant association with oligozoospermia, is 
located 445.4 kb downstream of TUSC1. According to LD and conditional logistic 
regression analysis adjusted for each SNP, rs12376894 and rs12348 are individually 
related to male infertility. It is known that SNPs within non-coding regions (intronic, 
intergenic, etc.) may influence expression regulation of genes both local to and distant 
from the locus [28]. Though significant expression quantitative trait loci (eQTL) of 
rs12376894 were not found in the GTEx Portal database [29], this SNP may contribute 
to the regulation of TUSC1 expression. 
 Liu et al. reported that rs10129954 is strongly associated with idiopathic male 
infertility (asthenozoospermia, oligozoospermia, and oligoasthenozoospermia) in 
Chinese Han people [30]. In the current study, we found a similar relationship in a 
Japanese population. rs10129954 is located in an intronic region of DPF3. DPF3 
protein is a member of the BRG1-associated factor (BAF) chromatin remodeling 
complex (SWI/SNF-like complex), with binding acetylated and methylated H3 and H4 
lysine residues, and regulates the transcription during heart and muscle development 
[31]. It is known that the SWI/SNF chromatin remodeling complex has an important 
role throughout spermatogenesis [32, 33], especially during male meiosis [34]. DPF3 is 
strongly expressed in the human testis as well as in the ovaries, heart, and brain [35]. It 
is suggested that DPF3 may contribute to spermatogenesis via chromatin remodeling. 
However, it is unclear whether the intronic variant rs10129954 influences DPF3. 
 In conclusion, we found that polymorphisms in TUSC1 and DPF3 displayed 
strong associations with male infertility. The effect of these polymorphisms on 
spermatogenesis remains unknown. To study this, functional analyses using genetically 
modified animals are required. In addition, in this study, the sample size of case subject 
was not very large. Therefore, further studies with larger sample size are also required to 
achieve the sufficient statistical power. 
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Table 1. Genotype and allele frequencies of rs12376894 and rs10129954 SNPs in the subjects. 
 
 
 
 
 
 
 
 
 
 
 
 
aAllele indicates control subject minor/major allele. 
bGenotypes indicate control subject minor homozygote/heterozygote/major homozygote. 
cAF indicates the allele frequency of the control subject minor alleles. 
Abbreviations: Chr, chromosome; dwnst., downstream; upst., upstream; Dist., distance. 
Gene names: TUSC1, tumor suppressor candidate 1; IZUMO3, IZUMO family member 3; DPF3, D4, zinc and double plant homeodomain fingers, family 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
       Control  Case 
  Position Closest    (n = 713)  
Azoospermia 
(n = 83) 
 
Oligozoospermia 
(n = 62) 
SNP Chr (NCBI Build 37) Genes Location Dist. (kb) Allelea Genotypesb AFc  Genotypesb AFc  Genotypesb AFc 
rs12376894 9 25,268,867 TUSC1 dwnst. 445.4 A/G 152/364/197 0.47  13/45/25 0.43  22/25/15 0.56 
   IZUMO3 upst. 687.8          
rs10129954 14 73,150,701 DPF3 intron − C/T 1/89/623 0.06  2/16/65 0.12  1/17/44 0.15 
Table 2. The associations derived from different comparative genetic models (additive, recessive, and dominant) between two SNPs (rs12376894 and rs10129954) 
and azoospermia, and oligozoospermia. 
 
 
 
 
 
 
 
 
 
 
Data are shown as odds ratio (OR), 95 % confidence interval (CI), and P-value. 
Bold numbers indicate P-value < 0.05. 
aLog-additive, additive model in log-odds scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Azoospermia  Oligozoospermia 
SNP Model OR (95% CI) P-value  OR (95% CI) P-value 
rs12376894 Log-additive (Risk allele, A)a 0.84 (0.61–1.17) 0.31  1.43 (0.99–2.07) 0.60 
 Recessive (AA vs. AG+GG) 0.69 (0.37–1.27) 0.23  2.03 (1.17–3.52) 0.012 
 Dominant (AA+AG vs. GG) 0.89 (0.54–1.46) 0.63  1.20 (0.65–2.19) 0.56 
rs10129954 Log-additive (Risk allele, C)a 2.05 (1.21–3.46) 7.4 × 10-3  2.83 (1.61–4.97) 2.9 × 10-4 
 Recessive (CC vs. CT+TT) 17.60 (1.58–196.00) 0.020  11.70 (0.72–189.00) 0.084 
 Dominant (CC+CT vs. TT) 1.92 (1.09–3.38) 0.025  2.83 (1.57–5.11) 5.6× 10-4 
Table 3. Allele and genotype frequencies of rs12348 in TUSC1 and rs2772579 in IZUMO3 in the study group. 
 
 
 
 
 
 
 
aAllele indicates control subject minor/major allele. 
bGenotypes indicate control subject minor homozygote/heterozygote/major homozygote. 
cAF indicates the frequency of the control subject minor alleles. 
Gene names: TUSC1, tumor suppressor candidate 1; IZUMO3, IZUMO family member 3. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     Control  Case 
 Position    (n = 713)  
Azoospermia  
(n = 83) 
 
Oligozoospermia 
(n = 62) 
SNP (NCBI Build 37) Genes Function Allelea Genotypesb AFc  Genotypesb AFc  Genotypesb AFc 
rs12348 25,677,217 TUSC1 3'-UTR T/C 112/345/256 0.40  21/37/25 0.48  23/23/16 0.56 
rs2772579 24,545,695 IZUMO3 5'-UTR G/C 28/250/435 0.21  1/25/57 0.16  3/21/38 0.22 
Table 4. The associations derived from different comparative genetic models (additive, recessive, and dominant) between the SNPs, rs12348 (in TUSC1) and 
rs2772579 (in IZUMO3), and azoospermia and oligozoospermia. 
 
 
 
 
 
 
 
 
 
Data are shown as odds ratio (OR), 95 % confidence interval (CI), and P-value. 
Bold numbers indicate P-value < 0.05. 
aLog-additive, additive model in log-odds scale. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  Azoospermia  Oligozoospermia 
SNP Model OR (95% CI) P-value  OR (95% CI) P-value 
rs12348 Log-additive (Risk allele, T)a 1.37 (0.99–1.89) 0.058  1.87 (1.29–2.71) 8.8 × 10-4 
 Recessive (TT vs. TC+CC) 1.82 (1.07–3.10) 0.028  3.16 (1.82–5.50) 4.5 × 10-5 
 Dominant (TT+TC vs. CC) 1.30 (0.79–2.13) 0.30  1.61 (0.89–2.90) 0.11 
rs2772579 Log-additive (Risk allele, G)a 0.70 (0.45–1.09) 0.11  1.02 (0.65–1.60) 0.93 
 Recessive (GG vs. GC+CC) 0.30 (0.04–2.22) 0.24  1.24 (0.37–4.21) 0.73 
 Dominant (GG+GC vs. CC) 0.71 (0.44–1.16) 0.18  0.99 (0.58–1.68) 0.97 
Table 5. Conditional logistic regression analysis for azoospermia, and oligozoospermia under three genetic models (additive, recessive, and dominant). 
 
 
 
 
 
 
 
 
 
 
Data are shown as odds ratio (OR), 95 % confidence interval (CI), and P-value with adjusted with each SNPs. 
Bold numbers indicate P-value < 0.05. 
aLog-additive, additive model in log-odds scale. 
 
 
  Azoospermia  Oligozoospermia 
SNP Model OR (95% CI) P-value  OR (95% CI) P-value 
rs12376894 Log-additive (Risk allele, T)a 0.86 (0.62-1.19) 0.36  1.47 (1.01–2.14) 0.042 
 Recessive (TT vs. TC+CC) 0.69 (0.37-1.28) 0.23  2.10 (1.20–3.68) 9.2 × 10-3 
 Dominant (TT+TC vs. CC) 0.90 (0.55-1.47) 0.67  1.23 (0.67–2.25) 0.50 
rs12348 Log-additive (Risk allele, T)a 1.36 (0.98-1.87) 0.065  1.91 (1.32–2.77) 6.4 × 10-4 
 Recessive (TT vs. TC+CC) 1.82 (1.06-3.10) 0.029  3.24 (1.85–5.66) 3.6 × 10-5 
 Dominant (TT+TC vs. CC) 1.29 (0.79-2.12) 0.31  1.63 (0.90–2.94) 0.11 
